AbbVie hikes dividend by 5.5%
On October 31, 2025, AbbVie (ABBV) announced a 5.5% dividend increase to $1.73 per share quarterly. Based on a share price of $218, the dividend yield is 2.9%. The ex-dividend date is January 16, 2026.
AbbVie Inc. (NYSE: ABBV), a leading biopharmaceutical company known for treatments in immunology and oncology, raised its quarterly dividend by 5.5% to $1.73 per share. The new annualized payout of $6.92 per share equates to a 2.9% yield based on a share price of $218. The ex-dividend date is January 16, 2026.
This marks the 54th consecutive year of dividend growth for AbbVie and its predecessor Abbott. Over the past five years, AbbVie’s dividend has increased at a compound annual growth rate of 5.9%, underscoring its consistent shareholder return policy.
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Investors should conduct their own research or consult with a financial advisor before making any investment decisions.